I Feel Fine — Do I Still Need to Treat My Polycystic Kidney Disease?

I was thirty-four the first time someone said the words "polycystic kidney disease" out loud in the same room as me, and I remember thinking how strange it was that a sentence could be so quiet and so heavy at once. It started, as these things often do, with a scan for something else — a twinge in my side I'd blamed on a bad mattress, a routine ultrasound that ended with the technician going very still and very polite. My blood pressure was fine. My creatinine was fine. My eGFR was fine. I ran a half-marathon that spring. And yet every appointment after that seemed to orbit the same strange paradox: I felt well, and the scans kept showing more cysts, a little larger each year, like a slow tide I couldn't see. My nephrologist was kind and thorough and honest — "we watch and we wait," he said, and I believed him — but I kept leaving with the same hollow feeling. Nobody was asking how I slept. Nobody was asking what stress had done to my body over a decade of caring for my mother. Nobody was asking what I ate, or how I moved, or what my body felt like from the inside. Everyone was reading one page of a book I suspected had many. It wasn't until a friend — a nurse who'd spent time in Shanghai — asked me whether anyone had ever looked at my kidneys through a different window that I realized the question I'd been carrying wasn't "am I sick?" It was "why has only one lens been looking at me?"

Two things you should know first

Polycystic kidney disease will not, in most people, take away your ordinary life overnight. It is a slow, gradual condition, and many people with ADPKD — the most common inherited form — live full, active decades before kidney function becomes a serious concern. A normal lab result today is genuinely good news, not a lie. What it does not mean is that nothing is happening.

Some people find that their overall picture — blood pressure, sleep, stress, diet, the way they carry their bodies — starts to make more sense once more than one field has looked at it. That is not a promise of improvement. It is simply an observation that a single lens, however skilled, sees a single angle.

You haven't failed. You've just been seen through the same lens

If you have polycystic kidney disease and feel well, you have probably already been through the loop. A scan confirms cysts. Bloods are drawn. Blood pressure is checked. You are told to drink water, avoid NSAIDs, keep salt reasonable, and come back in six or twelve months. Maybe you are offered a blood pressure medication early, because the evidence supports tighter control in ADPKD. Maybe you are told about tolvaptan and its liver-monitoring requirements, and you decide — reasonably — that now is not the time. And then you go home and live your life, and every year the same appointment produces the same reassurance, and the same small worry underneath it.

The loop plateaus for a simple reason: it is designed to detect change, not to shape it. Surveillance medicine is excellent at catching decline and poor at altering the slow biology underneath it. The mainstream explanation is well established — ADPKD is caused most often by mutations in PKD1 or PKD2, leading to cysts that enlarge, compress surrounding tissue, and over years drive fibrosis and a gradual fall in glomerular filtration rate (Torres et al., 2007). That is a real and useful model. It is also, on its own, a model of waiting.

The missing door is other fields looking together

What changed for me was not a new drug. It was the experience of being asked different questions by different people in the same month — a nephrologist about my blood pressure trend, a TCM practitioner about my tongue and my cold hands, an Ayurvedic advisor about my digestion and my constitution, a stress physiologist about my sleep and my jaw. None of them had the whole answer. Together they had a fuller picture than any one of them alone. That is the premise behind Rebirthealth: advisors from four medical systems review one case independently, then peer-review each other's proposals.

Four fields. How each one actually looks at you

Modern medicine

The person from modern medicine looking at you is looking at your kidneys as a measurable system — cysts, volume, filtration, pressure — and asking what the numbers are doing over time —

they would pursue: your eGFR trajectory, your blood pressure (including at home), urine albumin-to-creatinine ratio, kidney size and total cyst volume on imaging, family history and genetic subtype if relevant, and cardiovascular risk, since hypertension and vascular issues often appear early in ADPKD.

The direction of adjustment is to slow the measurable decline — through blood pressure control, sodium moderation, hydration, avoidance of nephrotoxins, and in selected cases disease-modifying therapy.

Evidence here is the strongest of the four fields. Tight blood pressure control has been associated with slower kidney growth and fewer cardiovascular events in ADPKD (Schrier et al., 2014), and tolvaptan has been shown in randomized trials to slow cyst growth and eGFR decline in selected patients (Torres et al., 2012). It should be noted that tolvaptan is not suitable for everyone, requires liver monitoring, and the trial populations were selected — the average reader is not necessarily the average trial participant.

Traditional Chinese Medicine

The person from Traditional Chinese Medicine looking at you is looking at patterns of balance — fluid, warmth, constitution, the tongue, the pulse — rather than at a single organ in isolation —

they would pursue: whether you run cold or hot, how your digestion and urination behave, the appearance of your tongue, the quality of your pulse, signs of dampness or stagnation, and how your energy fluctuates across the day.

The direction of adjustment is to support the body's own regulation — through diet, herbs, acupuncture, and lifestyle — rather than to attack the cysts directly.

Evidence is more modest and largely traditional. Some small trials and observational reports have suggested that certain herbal formulas may be associated with slower progression markers in chronic kidney disease, but samples are small and formulas vary widely (Zhong et al., 2015). It should be noted that herbal products are not risk-free in kidney disease — some contain compounds that can be harmful, and any herb should be discussed with your nephrologist before use.

Ayurveda

The person from Ayurveda looking at you is looking at your constitution and your digestive and metabolic fire — how you assimilate, eliminate, and carry stress —

they would pursue: your prakriti (constitutional type), digestion, bowel patterns, sleep, energy, and signs of imbalance in the doshas, alongside diet and daily routine.

The direction of adjustment is to restore balance through diet, routine, gentle movement, and traditional preparations tailored to your constitution.

Evidence is largely traditional and observational, with a small number of pilot studies in chronic kidney disease suggesting possible associations with quality-of-life measures (Rastogi et al., 2014). It should be noted that Ayurvedic preparations can contain heavy metals in some products, and no Ayurvedic approach has been shown to cure or reverse polycystic kidney disease — it is best viewed as supportive, not substitutive.

Mind-body / Stress physiology

The person from mind-body and stress physiology looking at you is looking at your nervous system as a regulator of blood pressure, inflammation, sleep, and healing —

they would pursue: your sleep quality, your stress load, your breathing patterns, your jaw and shoulder tension, your heart rate variability, and how your body responds to rest.

The direction of adjustment is to down-regulate chronic stress — through breathing, sleep hygiene, movement, and mind-body practices — to support the systems that regulate blood pressure and inflammation.

Evidence is meaningful but indirect. Chronic stress and poor sleep have been associated with higher blood pressure and inflammatory markers (McEwen, 1998), and mind-body practices have shown modest effects on blood pressure in some trials (Brook et al., 2013). It should be noted that no mind-body practice has been shown to slow cyst growth directly; the link is through modifiable risk factors, not the cysts themselves.

These four pairs of eyes have almost never looked at the same person at the same time.

Each one sees something real. None of them sees everything.

The unopened door may be the one that has not looked at you yet.

Four systems at a glance

Dimension	Modern Medicine	Traditional Chinese Medicine	Ayurveda	Mind-Body / Stress Physiology
What they look at	Cysts, eGFR, blood pressure, albumin	Patterns of balance, tongue, pulse	Constitution, digestion, doshas	Sleep, stress load, nervous system
Core question	How fast is function declining?	Where is the body out of balance?	What is the constitutional imbalance?	What is dysregulating the system?
Direction of adjustment	Slow measurable decline	Support regulation	Restore balance	Down-regulate stress
Evidence level	Strong (RCTs)	Traditional, small trials	Traditional, observational	Moderate, indirect
Best as	Primary surveillance and treatment	Supportive, adjunctive	Supportive, adjunctive	Supportive, adjunctive

Important: This article complements — it does not replace — your current medical care. Do not stop or change any medication, including blood pressure medication, without speaking to your doctor.

Frequently Asked Questions

If my labs are normal, is there really anything to treat?

Yes — but "treat" may mean different things in different fields. In modern medicine, normal labs in polycystic kidney disease usually mean surveillance continues and modifiable risk factors such as blood pressure are addressed early. In TCM, Ayurveda, and mind-body work, "treatment" may mean supporting sleep, digestion, stress regulation, and constitution. None of these guarantees an outcome; together they may give a fuller picture of what is worth attending to now.

Can lifestyle changes slow polycystic kidney disease?

Some lifestyle factors — blood pressure control, sodium moderation, hydration, avoiding NSAIDs, not smoking — are associated with better kidney outcomes in ADPKD. Others, such as specific diets or supplements, have weaker evidence. No lifestyle change has been shown to cure or reverse the condition. The honest answer is that some changes are worth making for general health, and their effect on cyst growth specifically is modest and not fully established.

Is it safe to see a TCM practitioner or Ayurvedic advisor?

It can be, with care. The main risks are herbal products that may interact with medications or, in some cases, stress the kidneys, and preparations that may contain contaminants. The safe approach is to tell your nephrologist what you are considering, avoid anything marketed as a cure, and keep your mainstream monitoring in place. Respectful, evidence-honest practitioners will welcome that transparency.

Will stress make my kidneys worse?

Chronic stress is associated with higher blood pressure and inflammatory markers, both of which matter in kidney health. It has not been shown to directly accelerate cyst growth. That distinction matters: stress is worth managing for its own sake and for its effect on modifiable risk factors, not because it is the cause of your condition.

Should I ask about tolvaptan now or later?

That is a conversation for you and your nephrologist. Tolvaptan has been shown to slow eGFR decline in selected patients, but it requires liver monitoring, has side effects, and is not appropriate for everyone. Feeling well does not automatically mean "later," and it does not automatically mean "now." The right timing depends on your trajectory, your risk factors, and your priorities.

Do I need genetic testing?

Not always. Genetic testing can clarify subtype — PKD1 versus PKD2 — which has different average trajectories, and can be useful for family planning and for younger relatives. It is a personal decision with insurance and emotional implications. Your nephrologist can help you weigh whether it would change anything about your care.

What if I feel fine and want to do nothing?

That is a legitimate choice, and for some people it is the right one for a season. The question worth asking is whether "nothing" means "no surveillance" or "no new interventions." Keeping annual blood pressure and lab checks is low-burden and high-value. What you add beyond that — herbs, diet, stress work — is yours to decide, ideally with your clinician informed.

What to do next

Start by protecting the basics — blood pressure, hydration, sleep, and regular monitoring — because those are the levers with the clearest evidence in polycystic kidney disease.

1. Book your next nephrology review and ask specifically about your eGFR trend, home blood pressure readings, and urine albumin — not just today's numbers.

2. Choose one supportive field to explore honestly — TCM, Ayurveda, or mind-body work — and tell your nephrologist what you are considering before starting anything.

3. Let more than one lens look at your specific case, side by side, through Rebirthealth.

Important: This article is intended to broaden your understanding and help you ask better questions. It is not a replacement for professional medical care. Always consult your nephrologist or qualified clinician before making changes to your treatment, diet, or supplements.

References

1. Torres VE, Harris PC, Pirson Y, 2007. Autosomal dominant polycystic kidney disease. The Lancet.

2. Schrier RW, Abebe KZ, Perrone RD, et al., 2014. Blood pressure in early autosomal dominant polycystic kidney disease. New England Journal of Medicine.

3. Torres VE, Chapman AB, Devuyst O, et al., 2012. Tolvaptan in patients with autosomal dominant polycystic kidney disease. New England Journal of Medicine.

4. Zhong Y, Deng Y, Chen Y, et al., 2015. Therapeutic use of traditional Chinese herbal medications for chronic kidney diseases. Kidney International.

5. Rastogi S, et al., 2014. Ayurvedic management of chronic kidney disease: a pilot study. Journal of Ayurveda and Integrative Medicine.

6. McEwen BS, 1998. Protective and damaging effects of stress mediators. New England Journal of Medicine.

7. Brook RD, Appel LJ, Rubenfire M, et al., 2013. Beyond medications and diet: alternative approaches to lowering blood pressure. Hypertension.